Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors

Clinical trial NCT01970540 · COMPLETED

Trial details

NCT number: NCT01970540
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Adenocarcinomas Neuroendocrine Tumors Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy

Start date: 2011-05-25
Primary completion: 2017-08-09
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.